Short answer: Postpartum depression (PPD) is a common and highly treatable mood disorder affecting 1 in 7 US mothers (ACOG, CDC). Postpartum depression symptoms include persistent sadness, loss of interest, fatigue, sleep disturbance, excessive guilt, difficulty bonding with baby, intrusive thoughts, anxiety, and in severe cases thoughts of self-harm or harming the baby. Treatment options approved and used in the United States include Cognitive Behavioural Therapy (CBT), Interpersonal Therapy (IPT), SSRIs (sertraline is first-line in breastfeeding mothers), SNRIs, and the newer FDA-approved rapid-acting medications brexanolone (Zulresso) and zuranolone (Zurzuvae). Call 988, the Maternal Mental Health Hotline 1-833-TLC-MAMA (1-833-852-6262), or 911 for a mental health crisis.
Table of Contents
- What Postpartum Depression Is
- Baby Blues vs PPD vs Psychosis
- Symptoms of Postpartum Depression
- Risk Factors
- Screening — EPDS and PHQ-9
- Causes and Biology
- Treatment Options
- Zuranolone (Zurzuvae) and Brexanolone
- Breastfeeding Compatibility
- When to Seek Urgent Help
- Support Resources in the US
- FAQs
- References
1. What Postpartum Depression Is
Postpartum depression is a major depressive episode with onset during pregnancy or within the first year after delivery (DSM-5-TR peripartum-onset specifier). It differs from the common and self-limited baby blues in duration, severity, and functional impact. The CDC estimates ~13% of US mothers experience postpartum depression; the Office on Women’s Health notes rates are higher among younger, lower-income, uninsured, Black, Indigenous, and Hispanic mothers — not a reflection of character but of life stressors and access.
2. Baby Blues vs PPD vs Psychosis
- Baby blues: 50–80% of mothers; starts day 2–3, resolves by day 14; mild tearfulness and mood lability
- Postpartum depression: 10–15% of mothers; onset within 4 weeks per DSM-5-TR, up to 1 year clinically; interferes with function
- Postpartum psychosis: 1–2 per 1,000 births; onset usually first 2 weeks; hallucinations, delusions, disorganised thinking, risk of suicide and infanticide — psychiatric emergency, call 911
3. Postpartum Depression Symptoms
Common postpartum depression symptoms include:
- Persistent sadness, emptiness, or hopelessness
- Loss of interest or pleasure (anhedonia)
- Severe fatigue beyond expected postpartum tiredness
- Difficulty bonding with the baby
- Appetite change — eating too much or too little
- Sleep problems despite baby’s sleep
- Intense irritability or anger
- Feelings of worthlessness, shame, guilt
- Difficulty concentrating or making decisions
- Thoughts of harming self or baby
- Severe anxiety, panic attacks, intrusive thoughts
- Social withdrawal
4. Risk Factors
- Personal or family history of depression, bipolar disorder, or PPD
- Antenatal depression or anxiety
- Teenage pregnancy, unplanned pregnancy
- Lack of social support, intimate partner violence
- Pregnancy complications, preterm birth, NICU stay
- Breastfeeding difficulties
- Thyroid dysfunction
- Low vitamin D, iron, or B12 (correct any deficiency)
- Financial stress, food insecurity
- Loss of a prior pregnancy or child
5. Screening — EPDS and PHQ-9
The Edinburgh Postnatal Depression Scale (EPDS) is the most widely used in US obstetric practice — 10 items; score ≥10 suggests depression, ≥13 highly concerning. The Patient Health Questionnaire-9 (PHQ-9) is also validated. ACOG and the USPSTF recommend universal screening at least once during pregnancy and at the postpartum visit; many practices screen at every visit through 12 months.
6. Causes and Biology
Postpartum depression is multifactorial:
- Rapid drop in estrogen and progesterone after delivery
- Sudden fall in allopregnanolone, a neurosteroid that modulates GABA-A receptors — the target of brexanolone and zuranolone
- Hypothalamic-pituitary-adrenal (HPA) axis dysregulation
- Postpartum thyroiditis
- Sleep deprivation
- Psychosocial stressors, relationship strain
- Genetics and prior mood disorder
7. Treatment Options
Evidence-based, US-insurance-covered options:
- Cognitive Behavioural Therapy (CBT) — first-line for mild to moderate PPD
- Interpersonal Therapy (IPT) — strong evidence for perinatal depression
- Group therapy and peer support (Postpartum Support International)
- Telehealth options (expanded under CMS post-2020)
- SSRIs — sertraline first-line in breastfeeding; also fluoxetine, escitalopram, paroxetine
- SNRIs — venlafaxine, duloxetine
- Bupropion — for low energy/concentration without comorbid anxiety
- Brexanolone (Zulresso) and zuranolone (Zurzuvae) — see below
- Sleep protection (partner / family share night feeds), light therapy, physical activity, correction of nutrient deficiency
8. Zuranolone (Zurzuvae) and Brexanolone
These rapid-acting neurosteroid modulators were developed specifically for postpartum depression:
- Brexanolone (Zulresso) — FDA approved March 2019; a synthetic form of allopregnanolone; a 60-hour continuous IV infusion in a certified US inpatient setting under REMS. Rapid, often same-day improvement.
- Zuranolone (Zurzuvae) — FDA approved August 2023; the first oral rapid-acting medication for PPD. 50 mg nightly ×14 days. Response often by day 3; durable through 45-day follow-up. Not approved for major depressive disorder generally (only for PPD).
Both are considered when depression is moderate-to-severe or when rapid improvement is needed to protect mother-infant bonding. Common side effects of zuranolone: somnolence, dizziness, headache. Must avoid driving within 12 h of each dose.
9. Breastfeeding Compatibility
Most SSRIs (sertraline especially) are compatible with breastfeeding — the LactMed database (NIH) is the US reference. Zuranolone has limited lactation data; consult with your clinician. Mothers should not stop lifesaving mental health medication to breastfeed; both breastfeeding and formula are valid, healthy options.
10. When to Seek Urgent Help
- Thoughts of harming self or baby — call 988 or 911
- Hearing voices, seeing things not there, or feeling your baby is in danger — call 911
- Severe inability to care for self or baby
- Severe depression lasting >2 weeks
- Panic attacks, severe anxiety
- Any new or worsening mental health symptom in the first year postpartum
11. Support Resources in the US
- Maternal Mental Health Hotline: 1-833-TLC-MAMA (1-833-852-6262) — 24/7, free, confidential
- 988 Suicide and Crisis Lifeline
- Postpartum Support International: 1-800-944-4773; postpartum.net
- National Maternal Mental Health Alliance
- Local Medicaid 12-month postpartum coverage (most US states)
- Online CBT platforms via commercial insurance and employer EAP
- Postpartum support groups via YMCA, La Leche League, local hospitals
- Peer support via certified doulas and community health workers
Related reading: See warning signs after childbirth that need medical attention, fever in babies: when to call a doctor, and infant feeding: common questions new parents ask. If you have broader mental-health symptoms, read depression and anxiety symptoms and treatment of adult depression in the United States.
12. External Video Resource
NIMH + ACOG: Postpartum Depression Explained (YouTube)
13. FAQs
Q1. How is postpartum depression different from baby blues?
Baby blues is mild, brief (first 2 weeks). PPD is more severe, lasts weeks to months, and affects function.
Q2. Can fathers get postpartum depression?
Yes — paternal/non-birthing-partner postnatal depression affects ~8–10% of US fathers.
Q3. How soon does zuranolone work?
Many patients see benefit within 3 days; 14-day oral course. Durable through 45 days in trials.
Q4. Can I breastfeed while taking SSRIs?
Most SSRIs — especially sertraline — are considered compatible. Check LactMed and consult your clinician.
Q5. Does postpartum depression go away on its own?
Sometimes mild cases improve, but moderate-to-severe PPD usually requires treatment. Untreated PPD can last 1–2 years and affects child development.
Q6. Will my insurance cover PPD treatment?
Under Mental Health Parity, most US commercial plans cover therapy and medication. Medicaid now covers 12-month postpartum care in most states.
Q7. Can I get PPD after a miscarriage or stillbirth?
Yes — perinatal grief and depression are real; the same resources apply.
14. Prevention Tips
- Universal EPDS/PHQ-9 screening at prenatal visits and postpartum
- Treat antenatal depression promptly
- Build a postpartum support plan before delivery
- Share night-feeds; protect maternal sleep
- Correct iron, B12, D deficiencies
- Screen and treat thyroid dysfunction
- Join a postpartum support group
- Early paediatric and OB follow-up
15. Conclusion
Learning the postpartum depression symptoms, treatment and when to seek help is a critical step for every US mother and family. PPD is common, treatable, and nothing to be ashamed of. With screening, CBT/IPT, SSRIs, and now rapid-acting zuranolone (Zurzuvae) and brexanolone (Zulresso), most mothers reach full remission. The US system is actively expanding support — the Maternal Mental Health Hotline, 988, 12-month Medicaid coverage, and improved screening protocols are transforming perinatal mental health care.
👨⚕️ Author & Medical Reviewer: Dr Sagar Rajkuwar
MBBS, MS (ENT), Nashik, Maharashtra, India
🏥 Visit: www.entspecialistinnashik.com
📞 For postpartum mental health, call 1-833-TLC-MAMA, 988, or your US OB-GYN / psychiatrist.
16. References
- ACOG. Screening and Diagnosis of Mental Health Conditions During Pregnancy and Postpartum, 2023.
- FDA. Zuranolone (Zurzuvae) approval announcement, August 2023.
- FDA. Brexanolone (Zulresso) approval, March 2019.
- CDC. Depression Among Women — Postpartum Depression Statistics, 2024.
- HRSA. National Maternal Mental Health Hotline, 2024.
- NIH LactMed Database, 2024.
- USPSTF. Perinatal Depression Screening, 2024.
Medical Disclaimer: This article is for educational and informational purposes only and does not substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider regarding any medical condition or before making any decisions related to your health. Do not disregard or delay seeking professional advice based on information provided in this article.



